Aprexis
Vermont corporation · 3 known investors
Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.
Digital HealthHealthtechSaaS
Founders & leadership
MH
MICHAEL HOWEExecutive Officer
RS
ROBERT SQUIREDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$721.5KraisedOct 2024 · 9 investors · Health InsuranceRule 506(b)
▶$721.5KraisedOct 2024 · 9 investors · Health Insurance
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL HOWEExecutive Officer
- ROBERT SQUIREDirector
- Offering amount
- $1.5M
- Amount sold
- $721.5K
- Minimum investment
- $10K
- Proceeds to insiders
- $150K
- First sale
- Sep 2023
- Incorporated
- Corporation, Vermont, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.